ACTIVE ROLE FOR THE VASCULATURE IN THE DELIVERY OF INSULIN TO SKELETAL MUSCLE
- 30 March 2005
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 32 (4), 302-307
- https://doi.org/10.1111/j.1440-1681.2005.04188.x
Abstract
1. In the 80+ years since insulin's discovery, an enormous amount of literature has accumulated relating to its actions on body fat, glucose and protein metabolism. In particular, skeletal muscle has been extensively studied because of its major role as a site of insulin-mediated glucose disposal. Liver and adipose tissue are two other extensively studied sites of insulin action. Much less investigation has been directed towards delineating insulin's actions on cells other than myocytes, adipocytes and hepatocytes. 2. Over the past 5-10 years it has become increasingly evident that insulin exerts important actions on vascular cells. Here, we review evidence that insulin's action within muscle may be very much regulated by its ability to transit the vasculature to access the interstitial fluid (and hence the myocyte insulin receptor). Surprisingly little is known regarding the regulation of vascular events that first bring insulin to the capillary endothelium within muscle, whence presumably it transits from the vascular to the interstitial space. Recent studies suggest that insulin can increase blood flow and also influence the distribution of blood flow within skeletal muscle, potentially therefore regulating its own delivery to the capillary endothelium. Beyond insulin's ability to access the vascular lumen within skeletal muscle microvasculature lies the issue of its passing the endothelial barrier. Even less is known about the processes involved in insulin's actual transit across the endothelium. Available data do not clearly indicate whether this is a saturable, receptor-mediated process or a passive-diffusion pathway. Also, whether insulin in any manner regulates its own transit across the endothelium or its clearance via the lymphatic system is entirely unknown. 3. The aim of the present review is to identify areas where knowledge is deficient and highlight hypotheses which may lead to a better understanding of the coordinated relationship between insulin's vascular actions within muscle and its metabolic actions in that tissue. Even so, there is now sufficient evidence to indicate that insulin's vascular action within skeletal muscle is a major regulatory locus for its insulin mediated glucose disposal.This publication has 47 references indexed in Scilit:
- The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptakeDiabetes/Metabolism Research and Reviews, 2003
- Insulin-stimulated Activation of eNOS Is Independent of Ca2+ but Requires Phosphorylation by Akt at Ser1179Published by Elsevier BV ,2001
- Recent advances in myocardial contrast echocardiographyCurrent Opinion in Cardiology, 1997
- Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.JCI Insight, 1996
- Nitric oxide release accounts for insulin's vascular effects in humans.JCI Insight, 1994
- Insulin regulation of renal glucose metabolism in conscious dogs.JCI Insight, 1994
- Sources of carbon for hepatic glycogen synthesis in the conscious dog.JCI Insight, 1991
- Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.JCI Insight, 1990
- Receptor-Mediated Transport of Insulin Across Endothelial CellsScience, 1985
- Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitusJCI Insight, 1972